Aimmune Therapeutics Inc (AIMT)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

8000 MARINA BOULEVARD BRISBANE, CA 94005-1884

Aimmune Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing treatments to protect children with food allergies from accidental exposure. Aimmune Therapeutics serves customers worldwide.

Data as of 2020-05-30
Market Cap1.084 Billion Shares Outstanding65.251 Million Avg 30-day Volume1.083 Million
P/E Ratio Dividend Yield EPS-4.44
Price/Sales1884.9 Price cash flow ratio Price free cash flow ratio-4.9
Book Value3.6 Price to Tangible Book4.72 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low37.0 / 10.09 Stddev
View SEC Filings from AIMT instead.

View recent insider trading info

Funds Holding AIMT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AIMT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

7.8 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MCDADE MARK

  • Director
34,692 2020-05-27 1

SELTZER STACEY DENENBERG

  • Director
18,061 2020-05-27 1

ENRIGHT PATRICK G

  • Director
6,191,535 2020-05-27 3

FALBERG KATHRYN E

  • Director
142,926 2020-05-27 1

IWICKI MARK T

  • Director
47,407 2020-05-27 1

BEHAR GREGORY

  • Director
18,032 2020-05-27 1

HAUMANN BRETT K

  • Director
19,563 2020-05-27 1

DILLY STEPHEN GEORGE

  • Director
7,500 2020-05-18 0

NESTLE HEALTH SCIENCE US HOLDINGS, INC.

SOCIETE DES PRODUITS NESTLE S.A.

NESTLE SA

NIMCO US, INC.

NESTLE US HOLDCO, INC.

  • 10% Owner
4,305,541 2020-05-18 0

SHEEHY DOUGLAS T. SEE REMARKS

  • Officer
55,378 2020-05-10 6

ADELMAN DANIEL C MD CHIEF MEDICAL OFFICER

  • Officer
29,715 2020-05-10 6

BJERKHOLT ERIC CHIEF FINANCIAL OFFICER

  • Officer
45,387 2020-05-10 7

DALLAS JAYSON DONALD ALEXANDER PRESIDENT AND CEO

  • Officer
  • Director
126,583 2020-05-10 5

OXTOBY ANDREW CHIEF COMMERCIAL OFFICER

  • Officer
27,435 2020-05-10 5

TAMMENOMS BAKKER JULIET

  • FORMER DIRECTOR
0 2020-02-14 0

SOCIETE DES PRODUITS NESTLE S.A.

NESTLE SA

  • 10% Owner
26,505,494 2020-02-07 1

ROZENMAN MARY M. SEE REMARKS

  • Officer
13,878 2019-12-31 1

BARROWCLIFFE SUSAN E. GENERAL MANAGER, EUROPE

  • Officer
9,375 2018-11-19 0

LONGITUDE CAPITAL PARTNERS II, LLC

LONGITUDE VENTURE PARTNERS II, L.P.

TAMMENOMS BAKKER JULIET

ENRIGHT PATRICK G

3,019,734 2018-07-02 0

LONGITUDE CAPITAL PARTNERS II, LLC

TAMMENOMS BAKKER JULIET

LONGITUDE VENTURE PARTNERS II, L.P.

  • 10% Owner
No longer subject to file 2018-06-25 0

KNAPP JEFFREY H CHIEF OPERATING OFFICER

  • Officer
12,151 2018-03-04 0

NESTLE HEALTH SCIENCE US HOLDINGS, INC.

NESTLE SA

NIMCO US, INC.

  • 10% Owner
11,727,113 2018-02-26 0

FORESITE CAPITAL MANAGEMENT II, LLC

FORESITE CAPITAL FUND II, L.P.

FORESITE CAPITAL MANAGEMENT III, LLC

FORESITE CAPITAL FUND III, L.P.

TANANBAUM JAMES B.

  • 10% Owner
3,643,191 2017-05-26 0

DESOUZA WARREN L. CHIEF FINANCIAL OFFICER

  • Officer
20,681 2017-04-03 0

ELFONT ROBERT MYLES CHIEF MEDICAL OFFICER

  • Officer
299,002 2016-02-26 0

FORESITE CAPITAL MANAGEMENT II, LLC

FORESITE CAPITAL FUND II, L.P.

TANANBAUM JAMES B.

  • 10% Owner
0 2015-08-05 0

RAFF HOWARD V. CHIEF OPERATING OFFICER

  • Officer
428,575 2015-08-05 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

SELTZER STACEY DENENBERG - Director

2020-05-27 A 15,398 a 15,398 18,061.00 direct

MCDADE MARK - Director

2020-05-27 A 7,840 a 34,692 34,692.00 direct

FALBERG KATHRYN E - Director

2020-05-27 A 15,398 a 15,398 142,926.00 direct

HAUMANN BRETT K - Director

2020-05-27 A 13,313 a 19,563 19,563.00 direct

IWICKI MARK T - Director

2020-05-27 A 15,398 a 15,398 47,407.00 direct

SELTZER STACEY DENENBERG - Director

2020-05-27 A 7,840 a 18,061 18,061.00 direct

ENRIGHT PATRICK G - Director

2020-05-27 A 15,398 a 15,398 6,191,535.00 direct

FALBERG KATHRYN E - Director

2020-05-27 A 7,840 a 73,032 142,926.00 direct

BEHAR GREGORY - Director

2020-05-27 A 15,398 a 15,398 18,032.00 direct

IWICKI MARK T - Director

2020-05-27 A 7,840 a 47,407 47,407.00 direct

MCDADE MARK - Director

2020-05-27 A 15,398 a 15,398 34,692.00 direct

ENRIGHT PATRICK G - Director

2020-05-27 S 7,840 a 78,401 6,191,535.00 direct

HAUMANN BRETT K - Director

2020-05-27 A 25,453 a 25,453 19,563.00 direct

BEHAR GREGORY - Director

2020-05-27 A 7,840 a 18,032 18,032.00 direct

SHEEHY DOUGLAS T. - Officer SEE REMARKS

2020-05-10 A 2,420 a 55,378 55,378.00 direct

DALLAS JAYSON DONALD ALEXANDER - Director - Officer PRESIDENT AND CEO

2020-05-10 A 3,300 a 126,583 126,583.00 direct

BJERKHOLT ERIC - Officer CHIEF FINANCIAL OFFICER

2020-05-10 A 2,420 a 45,387 45,387.00 direct

OXTOBY ANDREW - Officer CHIEF COMMERCIAL OFFICER

2020-05-10 A 2,420 a 27,435 27,435.00 direct

ADELMAN DANIEL C MD - Officer CHIEF MEDICAL OFFICER

2020-05-10 A 2,420 a 29,715 29,715.00 direct

SOCIETE DES PRODUITS NESTLE S.A. - > 10% Owner see footnote

NESTLE SA - > 10% Owner see footnote

2020-04-22 J 12,727,113 $16.11 a 12,727,113 26,505,494.00 indirect

SOCIETE DES PRODUITS NESTLE S.A. - > 10% Owner see footnote

NESTLE SA - > 10% Owner see footnote

2020-04-22 J 525,634 $161.10 a 525,634 26,505,494.00 indirect

Elevate your investments